Literature DB >> 8594918

Increased ACE and chymase-like activity in cardiac tissue of dogs with chronic mitral regurgitation.

L J Dell'Italia1, Q C Meng, E Balcells, I M Straeter-Knowlen, G H Hankes, R Dillon, R E Cartee, R Orr, S P Bishop, S Oparil.   

Abstract

The current study was designed to test the hypothesis that intracardiac angiotensin-converting enzyme (ACE) activity, chymase-like activity, and angiotensin (ANG) peptide levels are increased and are positively related to wall stress estimates in response to the chronic low pressure volume overload of mitral regurgitation produced by percutaneous chordal rupture in the dog. Chronic mitral regurgitation (MR) resulted in an increase in left ventricular (LV) end-diastolic volume [59 +/- 11 (SD) to 103 +/- 32 ml, P < 0.001], LV mass (96 +/- 17 to 114 +/- 23 g, P < 0.001), and a decrease in the LV mass-to-end-diastolic volume ratio (1.64 +/- 0.22 to 1.16 +/- 0.23 g/ml, P < 0.001) measured by magnetic resonance imaging. In vitro studies of heart tissue extracts demonstrated that the majority of ANG II-forming activity was from chymase-like activity rather than from ACE activity in five normal (83.5 +/- 7.5 vs. 6.04 +/- 5.2%) and seven MR hearts (86 +/- 3.9 vs. 2.6 +/- 1.7%). ACE activity (1.22 +/- 0.22 vs. 3.55 +/- 0.62 mU/g, P < 0.05) and chymase-like activity (9.42 +/- 4.64 vs. 20.60 +/- 8.41 nmol.g-1.min-1, P < 0.05) were increased in MR compared with normal hearts. ACE activity correlated with the LV mass-to-volume ratio (r = -0.93, P < 0.001) and LV diastolic wall stress ( r = 0.71, P < 0.05); however, chymase-like activity did not correlate with any hemodynamic parameter. ANG II levels were significantly higher in the midwall of the left ventricle in MR hearts than in normal controls (85 +/- 39 vs. 27 +/- 16 pg/g, P < 0.01). Our results demonstrate a positive correlation between LV diastolic wall stress and increased ACE activity with increased ANG II stores, suggesting that mechanical wall stress activated intracardiac ACE. Although chymase accounted for most ANG II formation in vitro in extracts of both normal and MR dog hearts, the significance of this enzyme in vivo remains unclear.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8594918     DOI: 10.1152/ajpheart.1995.269.6.H2065

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  24 in total

1.  Chymase inhibition prevents fibronectin and myofibrillar loss and improves cardiomyocyte function and LV torsion angle in dogs with isolated mitral regurgitation.

Authors:  Betty Pat; Yuanwen Chen; Cheryl Killingsworth; James D Gladden; Ke Shi; Junying Zheng; Pamela C Powell; Greg Walcott; Mustafa I Ahmed; Himanshu Gupta; Ravi Desai; Chih-Chang Wei; Naoki Hase; Tsunefumi Kobayashi; Abdelkarim Sabri; Henk Granzier; Thomas Denney; Michael Tillson; A Ray Dillon; Ahsan Husain; Louis J Dell'italia
Journal:  Circulation       Date:  2010-09-27       Impact factor: 29.690

2.  Angiotensin II potentiates adrenergic and muscarinic modulation of guinea pig intracardiac neurons.

Authors:  Allison E Girasole; Christopher P Palmer; Samantha L Corrado; E Marie Southerland; Jeffrey L Ardell; Jean C Hardwick
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2011-08-24       Impact factor: 3.619

Review 3.  Angiotensin-(1-12): a chymase-mediated cellular angiotensin II substrate.

Authors:  Sarfaraz Ahmad; Jasmina Varagic; Leanne Groban; Louis J Dell'Italia; Sayaka Nagata; Neal D Kon; Carlos M Ferrario
Journal:  Curr Hypertens Rep       Date:  2014-05       Impact factor: 5.369

Review 4.  The renin-angiotensin system in mitral regurgitation: a typical example of tissue activation.

Authors:  Louis J Dell'Italia
Journal:  Curr Cardiol Rep       Date:  2002-03       Impact factor: 2.931

5.  Angiotensin II stimulates hyperplasia but not hypertrophy in immature ovine cardiomyocytes.

Authors:  N C Sundgren; G D Giraud; P J S Stork; J G Maylie; K L Thornburg
Journal:  J Physiol       Date:  2003-03-07       Impact factor: 5.182

6.  Compartmentalization of angiotensin II generation in the dog heart. Evidence for independent mechanisms in intravascular and interstitial spaces.

Authors:  L J Dell'Italia; Q C Meng; E Balcells; C C Wei; R Palmer; G R Hageman; J Durand; G H Hankes; S Oparil
Journal:  J Clin Invest       Date:  1997-07-15       Impact factor: 14.808

7.  Critical role of the chymase/angiotensin-(1-12) axis in modulating cardiomyocyte contractility.

Authors:  Tiankai Li; Xiaowei Zhang; Heng-Jie Cheng; Zhi Zhang; Sarfaraz Ahmad; Jasmina Varagic; Weimin Li; Che Ping Cheng; Carlos M Ferrario
Journal:  Int J Cardiol       Date:  2018-04-21       Impact factor: 4.164

Review 8.  Optimal antagonism of the Renin-Angiotensin-aldosterone system: do we need dual or triple therapy?

Authors:  Christian Werner; Janine Pöss; Michael Böhm
Journal:  Drugs       Date:  2010-07-09       Impact factor: 9.546

9.  Chymase mediates angiotensin-(1-12) metabolism in normal human hearts.

Authors:  Sarfaraz Ahmad; Chih-Chang Wei; Jose Tallaj; Louis J Dell'Italia; Norihito Moniwa; Jasmina Varagic; Carlos M Ferrario
Journal:  J Am Soc Hypertens       Date:  2013-01-10

10.  Apoptosis after reperfused myocardial infarction: Role of angiotensin II.

Authors:  Bodh I Jugdutt
Journal:  Exp Clin Cardiol       Date:  2004
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.